(Q39854448)

15 September 2017

Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections (English)

1 reference

15 September 2017

1 reference

ChEBI release 2020-05-28

ChEBI ID

100246

urinary tract infection

1 reference

Hirai K

1

1 reference

15 September 2017

Ito A

2

1 reference

15 September 2017

Abe Y

3

1 reference

15 September 2017

Suzue S

4

1 reference

15 September 2017

Irikura T

5

1 reference

15 September 2017

Inoue M

6

1 reference

15 September 2017

Mitsuhashi S

7

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 January 1981

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

19

1 reference

15 September 2017

188-189

1 reference

15 September 2017

1

1 reference

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181380

PubMed Central

reference URL

Pipemidic Acid: Its Activities Against Various Experimental Infections

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181380

PubMed Central

reference URL

Pipemidic acid, a new antibacterial agent active against Pseudomonas aeruginosa: in vitro properties

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181380

PubMed Central

reference URL

25 September 2017

Identifiers

DOI

10.1128/AAC.19.1.188

1 reference

15 September 2017

1 reference

15 September 2017

1 reference